DK1383512T3 - Anvendelse af sucralfat til behandling af cervikal erosion - Google Patents

Anvendelse af sucralfat til behandling af cervikal erosion

Info

Publication number
DK1383512T3
DK1383512T3 DK01932070T DK01932070T DK1383512T3 DK 1383512 T3 DK1383512 T3 DK 1383512T3 DK 01932070 T DK01932070 T DK 01932070T DK 01932070 T DK01932070 T DK 01932070T DK 1383512 T3 DK1383512 T3 DK 1383512T3
Authority
DK
Denmark
Prior art keywords
sucralfate
treatment
cervical erosion
sucrose octasulfate
affection
Prior art date
Application number
DK01932070T
Other languages
English (en)
Inventor
Alberto Federighi
Pietro Bianchini
Enrico Boldrini
Gianfranco Gori
Aditeo Guidi
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Application granted granted Critical
Publication of DK1383512T3 publication Critical patent/DK1383512T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01932070T 2001-05-03 2001-05-03 Anvendelse af sucralfat til behandling af cervikal erosion DK1383512T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000212 WO2002089818A1 (en) 2001-05-03 2001-05-03 Use of sucralfate for the treatment of cervical erosion

Publications (1)

Publication Number Publication Date
DK1383512T3 true DK1383512T3 (da) 2004-11-15

Family

ID=11133654

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01932070T DK1383512T3 (da) 2001-05-03 2001-05-03 Anvendelse af sucralfat til behandling af cervikal erosion

Country Status (13)

Country Link
US (1) US20040192640A1 (da)
EP (1) EP1383512B1 (da)
KR (1) KR100765683B1 (da)
CN (1) CN1226037C (da)
AT (1) ATE275405T1 (da)
CA (1) CA2445506C (da)
DE (1) DE60105452T2 (da)
DK (1) DK1383512T3 (da)
ES (1) ES2227189T3 (da)
HK (1) HK1064607A1 (da)
MX (1) MXPA03009838A (da)
TR (1) TR200402446T4 (da)
WO (1) WO2002089818A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
ATE404209T1 (de) * 2005-09-16 2008-08-15 Italfar Societa A Responsabili Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine
FR2927808B1 (fr) * 2008-02-26 2011-04-29 Fabre Pierre Dermo Cosmetique Gel de sucralfate sterilise
KR101016364B1 (ko) * 2009-06-24 2011-02-21 (주)아트웨어 건축설비용 타일형 엘이디 외벽마감재
FR2977797B1 (fr) * 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
FR2977798B1 (fr) * 2011-07-13 2016-07-29 Urgo Lab Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
US10874721B2 (en) * 2015-12-18 2020-12-29 Talengen International Limited Method for preventing and treating cervical erosion
CN106890321A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种用于预防和治疗宫颈糜烂的方法
CN108463236A (zh) 2015-12-18 2018-08-28 泰伦基国际有限公司 一种预防或治疗放射性和化学性损伤的方法
CN107582806A (zh) * 2017-10-25 2018-01-16 桂林浩新科技服务有限公司 一种治疗宫颈糜烂的药物组合物及用途
CN107596075A (zh) * 2017-10-25 2018-01-19 桂林浩新科技服务有限公司 一种治疗宫颈炎的药物组合物配方及用途
CN107854471A (zh) * 2017-10-26 2018-03-30 郭裴哲 一种治疗宫颈糜烂的药物制剂及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69213010T2 (de) * 1991-04-15 1997-01-23 Applied Microbiology Inc Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
US5945446A (en) * 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
JPH1143333A (ja) * 1997-07-22 1999-02-16 Minolta Co Ltd 金型保護膜
AU2798299A (en) * 1998-02-27 1999-09-15 Althexis Company, The Therapeutic and prophylactic uses of negatively charged substituted disaccharides

Also Published As

Publication number Publication date
CN1226037C (zh) 2005-11-09
CA2445506C (en) 2009-04-14
KR20040018365A (ko) 2004-03-03
ATE275405T1 (de) 2004-09-15
TR200402446T4 (tr) 2004-12-21
US20040192640A1 (en) 2004-09-30
KR100765683B1 (ko) 2007-10-11
ES2227189T3 (es) 2005-04-01
CN1505518A (zh) 2004-06-16
DE60105452T2 (de) 2005-10-13
DE60105452D1 (de) 2004-10-14
WO2002089818A1 (en) 2002-11-14
CA2445506A1 (en) 2002-11-14
HK1064607A1 (en) 2005-02-04
EP1383512A1 (en) 2004-01-28
MXPA03009838A (es) 2004-09-13
EP1383512B1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
DK1383512T3 (da) Anvendelse af sucralfat til behandling af cervikal erosion
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NO20023884L (no) Fremgangsmåte for behandling eller profylakse av flavivirus- infeksjoner ved å anvende nukleosidanaloger
LU92595I2 (fr) Siméprévir, ou l'un de ses sels pharmaceutiquementacceptables, incluant siméprévir sodium
WO2004041203A3 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
EA200601591A1 (ru) Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
GB0112348D0 (en) Compounds
DK1441770T3 (da) Vaginal formulering af lidocain til behandling af livmoderdysrytmi
UY26851A1 (es) Derivados de la 4-fenilpiridina
CL2004000652A1 (es) Uso de lactulosa para la inhibicion de infecciones por rotavirus de celulas animales o humanas.
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
NO20040210L (no) Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
NO20020926D0 (no) Sf¶riske agglomerater av telitromycin, fremgangsmåte ved deres fremstilling og deres anvendelse for frestilling avfarmasöytiske former
HUP0402080A2 (hu) Kannabinoid receptor agonisták alkalmazása gastrooesophagealis reflux betegség kezelésére szolgáló gyógyszer előállítására
WO2003007923A3 (de) Verwendung von trifluoracetylalkyl-substituierte phenyl-, phenol- und benzoylderivate in der behandlung und/oder prophylaxe von obesitas und deren begleit- und/oder folgeerkrankungen
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
AU8726201A (en) Use of CRF receptor agonists for the treatment of prophylaxis of diseases, for example neurodegenerative diseases
NO20033981D0 (no) Imidazolidinderivater, deres fremstilling og deres anvendelse som antiinflammatorisk middel
EA200100876A3 (ru) Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12
PT1341539E (pt) Agentes anti-inflamatorios
BR0315445A (pt) Composição farmacêutica para o tratamento das patologias ligadas à hiperacidez gástrica e utilização combinada do tenatoprazol e de pelo menos um antagonista dos receptores h2 para a histamina
ITRM20010293A1 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.